• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EXACTECH, INC. ACUMATCH GXL 15DEG LINER 28MM SZ D; PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/CERAMIC/POLYMER, CEMENTED OR NON-POROUS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EXACTECH, INC. ACUMATCH GXL 15DEG LINER 28MM SZ D; PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/CERAMIC/POLYMER, CEMENTED OR NON-POROUS Back to Search Results
Catalog Number 132-28-24
Medical Device Problem Code Naturally Worn (2988)
Health Effect - Clinical Codes Failure of Implant (1924); Osteolysis (2377); Implant Pain (4561)
Date of Event 11/20/2018
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported via legal documentation that a patient had a right total hip arthroplasty on (b)(6) 2011, and then experienced revision surgical procedure on (b)(6) 2018 approximately 7 years and 6 months after initial implant.No images were provided.There is no other information available.
 
Additional Manufacturer Narrative
D10.Concomitant: 120-01-44 - acumatch cluster cup porous coated 44mm; (b)(6).This device is used in treatment and not in diagnosis.Pending investigation.
 
Additional Manufacturer Narrative
1038671-2024-00639 b1: corrected.B2: corrected.C6: corrected the following: health effect - clinical code, type of investigation, investigation findings, investigation conclusions.Manufacturer narrative: the most likely cause for the reported revision due to prosthesis wear and osteolysis is a combination of the risk factors such as use error, implant positioning, implant size selection, and patient factors (fitness for surgery, biomechanics, activity level and local tissue oxidation potential).Additionally, a contributing factor may have been using another manufacturer¿s femoral components with exactech acetabular components.However, this cannot be confirmed as the devices were not returned for evaluation, and images and radiographs were not provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACUMATCH GXL 15DEG LINER 28MM SZ D
Common Device Name
PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/CERAMIC/POLYMER, CEMENTED OR NON-POROUS
Manufacturer (Section D)
EXACTECH, INC.
2320 nw 66 court
gainesville FL 32653
Manufacturer (Section G)
EXACTECH INC.
2320 nw 66th court
gainesville FL 32653
Manufacturer Contact
michael crader
MDR Report Key18957686
Report Number1038671-2024-00639
Device Sequence Number4449604
Product Code LZO
UDI-Device Identifier10885862023063
UDI-Public10885862023063
Combination Product (Y/N)N
Initial Reporter StateFL
Initial Reporter CountryUS
PMA/510(K) Number
K051556
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2011
Device Explanted Year2018
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Company Representative
Initial Reporter Occupation Non-Healthcare Professional
Remedial Action Recall
Type of Report Initial,Followup
Report Date (Section B) 09/05/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date12/08/2013
Device Catalogue Number132-28-24
Was Device Available for Evaluation? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 10/27/2023
Supplement Date Received by Manufacturer08/21/2024
Initial Report FDA Received Date03/22/2024
Supplement Report FDA Received Date09/05/2024
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured12/09/2009
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
If action reported to FDA under 21 USC 360i(g), list
FDA-assigned Recall Number or include a statement
Z-1728-2022
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
SEE H10.
Outcome Attributed to Adverse Event Required Intervention; Hospitalization;
Patient SexFemale
-
-